At close: December 13 at 4:00:02 PM EST
After hours: December 13 at 5:19:03 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-211,644.00
-145,367.00
-92,517.00
-79,681.00
-70,804.00
Investing Cash Flow
-112,194.00
-223,623.00
-63,825.00
42,280.00
-9,761.00
Financing Cash Flow
370,357.00
353,316.00
255,632.00
602.00
203,107.00
End Cash Position
316,065.00
234,207.00
249,881.00
150,591.00
187,390.00
Interest Paid Supplemental Data
3,716.00
2,483.00
441.00
--
--
Capital Expenditure
--
--
--
--
-148.00
Issuance of Capital Stock
355,443.00
335,429.00
241,200.00
--
202,554.00
Issuance of Debt
10,000.00
15,000.00
10,000.00
--
--
Free Cash Flow
-212,643.00
-145,367.00
-92,517.00
-79,681.00
-70,952.00
12/31/2020 - 6/20/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ETNB 89bio, Inc.
7.69
-2.04%
STOK Stoke Therapeutics, Inc.
12.06
-2.11%
PLRX Pliant Therapeutics, Inc.
13.30
-3.97%
MDGL Madrigal Pharmaceuticals, Inc.
304.50
+0.67%
RARE Ultragenyx Pharmaceutical Inc.
45.78
-2.37%
BDTX Black Diamond Therapeutics, Inc.
2.5600
+2.40%
PTGX Protagonist Therapeutics, Inc.
41.08
+1.73%
SGMT Sagimet Biosciences Inc.
4.3900
-3.30%
YMAB Y-mAbs Therapeutics, Inc.
9.43
-3.48%
RVMD Revolution Medicines, Inc.
45.01
+0.18%